Publicaciones en colaboración con investigadores/as de Hospital Ramón y Cajal (37)

2014

  1. Documento de la sociedad española de nefrología sobre las guías KDIGO para la evaluación y el tratamiento de la enfermedad renal crónica

    Nefrologia, Vol. 34, Núm. 3, pp. 302-316

2011

  1. Abnormalities in ambulatory blood pressure monitoring in hypertensive patients with diabetes

    Hypertension Research, Vol. 34, Núm. 11, pp. 1185-1189

2007

  1. Antihypertensive effectiveness of lercanidipine administered using an electronic pillbox compared with usual care in a cohort of mild-to-moderately hypertensive patients: The ELECTRA study

    Therapy, Vol. 4, Núm. 4, pp. 433-440

  2. Cardiovascular risk profile and risk stratification of the hypertensive population attended by general practitioners and specialists in Spain. The CONTROLRISK study

    Journal of Human Hypertension, Vol. 21, Núm. 6, pp. 479-485

  3. Evolution of blood pressure control in Spain [2]

    Journal of Hypertension

2006

  1. Effect of NSAID on blood pressure among hypertensive patients with a high cardiovascular risk

    Anales de Medicina Interna, Vol. 23, Núm. 9

  2. Prevalence of renal insufficiency in individuals with hypertension and obesity/overweight: The FATH study

    Journal of the American Society of Nephrology

  3. The effectiveness and tolerability of lercanidipine is independent of body mass index or body fat percent. The LERZAMIG study

    British Journal of Cardiology, Vol. 13, Núm. 6, pp. 434-440

2005

  1. Estudio PREVENCAT: Control del riesgo cardiovascular en atención primaria

    Medicina Clinica, Vol. 124, Núm. 11, pp. 406-410

2004

  1. Blood pressure control and physician physician management of hypertension in hospital hypertension units in Spain

    Hypertension, Vol. 43, Núm. 6, pp. 1338-1344

  2. Hypertensive Renal Damage in Metabolic Syndrome Is Associated with Glucose Metabolism Disturbances

    Journal of the American Society of Nephrology

2003

  1. Hyperuricemia, low urine urate excretion and target organ damage in arterial hypertension

    Blood Pressure, Vol. 12, Núm. 5-6, pp. 277-283

2002

  1. Antihypertensive efficacy and tolerability of lercanidipine in daily clinical practice. The ELYPSE study

    Blood Pressure, Vol. 11, Núm. 2, pp. 95-100

  2. Hypertension magnitude and management in the elderly population of Spain

    Journal of Hypertension, Vol. 20, Núm. 11, pp. 2157-2164

  3. N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients

    Blood Pressure, Vol. 11, Núm. 4, pp. 235-239

2001

  1. Relationship between severity of essential hypertension and hyperuricemia

    Medicina Clinica, Vol. 117, Núm. 3, pp. 85-89

2000

  1. Renal implications of the renin-angiotensin-aldosterone system blockade in heart failure

    Journal of Hypertension, Vol. 18, Núm. 11, pp. 1545-1551

1998

  1. Effects of chronic combined treatment with captopril and pravastatin on the progression of insulin resistance and cardiovascular alterations in an experimental model of obesity in dogs

    American Journal of Hypertension, Vol. 11, Núm. 7, pp. 844-851

  2. Salt sensitivity: Concept and pathogenesis

    Diabetes Research and Clinical Practice, Vol. 39, Núm. SUPPL.

1997

  1. Effects of UP269-6, a new angiotensin II receptor antagonist, and captopril on the progression of rat diabetic nephropathy

    American Journal of Hypertension, Vol. 10, Núm. 3, pp. 275-281